Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
104.01
+0.03 (0.03%)
At close: May 29, 2026, 4:00 PM EDT
104.00
-0.01 (-0.01%)
After-hours: May 29, 2026, 7:54 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.53 billion as of May 29, 2026. Its market cap has increased by 872.45% in one year.
Market Cap
1.53B
Enterprise Value
1.55B
1-Year Change
872.45%
Ranking
Category
Stock Price
$104.01
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.53B, an increase of 669.76%. That is a compound annual growth rate of 177.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.53B | 32.81% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.61B |
| Precigen | 1.61B |
| uniQure | 1.57B |
| Ardelyx | 1.54B |
| Biohaven | 1.54B |
| GH Research | 1.54B |
| Immatics | 1.54B |
| Damora Therapeutics | 1.53B |